|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| C07D 471/04 | (2013.01) | ||
| A61K 31/4745 | (2006.01) | ||
| C07D 471/14 | (2013.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61P 25/28 | (2018.01) |
| (11) | Patento numeris | 3592740 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18711175.2 |
| Europos patento paraiškos padavimo data | 2018-03-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-01-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-02-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2018/051318 |
| Data | 2018-03-01 |
| (87) | Numeris | WO 2018/163030 |
| Data | 2018-09-13 |
| (30) | Numeris | Data | Šalis |
| 201762469768 P | 2017-03-10 | US |
| (72) |
CHAPPIE, Thomas Allen , US
GALATSIS, Paul , US
GARNSEY, Michelle Renee , US
HELAL, Christopher John , US
HENDERSON, Jaclyn Louise , US
KORMOS, Bethany Lyn , US
KURUMBAIL, Ravi G. , US
MARTINEZ-ALSINA, Luis Angel , US
PETTERSSON, Martin Youngjin , US
STEPAN, Antonia Friederike , DE
WAGER, Travis T. , US
|
| (73) |
Pfizer Inc. ,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | CYCLIC SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES |
| CYCLIC SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES |